Oct 16, 2018 - October's top net gain safer Healthcare WallStar is AbbVie. Its projected 23% net gain was 2.3% better than Sanofi's, and 3.4% more than Grifol's result per analyst targets of 10/12/18.WallStars all s
Oct 15, 2018 - Big pharma drug makers and biotech continued to top the healthcare sector by broker targets. WallStars are distinguished by positive broker target price upsides.The Healthcare sector is comprised of 1
Oct 15, 2018 - PFE vs. NVO: Which Stock Is the Better Value Option?
Oct 14, 2018 - Catalyst Biosciences is a micro-cap company focused on subcutaneous hemophilia treatments, and it appears that investors don’t buy the growth story.Price to tangible book value ratio is 1, even consid
Oct 01, 2018 - Novo Nordisk's Tresiba basal insulin was approved for the treatment of type-1 diabetes in Canadian children.Type-1 diabetes is rarer than type-2 diabetes, but it is still a growing market, with total
Sep 24, 2018 - Amgen is a high-quality business generating strong cash flows.Valuation is fairly reasonable.Earnings expectations are increasing.Winners tend to keep on winning in the stock market, and Amgen is deli
Sep 19, 2018 - Novo Nordisk (NVO) plans to restructure and reallocate resources in its Research and Development organization and lay off 400 employees from the unit.
Sep 17, 2018 - 3 High-Quality Biotech Companies for 4th Quarter, Stocks: BIIB,GILD,NVO,BRK.A,BRK.B,AMGN,CELG, Warren Buffett, release date:Sep 17, 2018
Sep 12, 2018 - Gilead took September's net gain safer Healthcare WallStar top spot. Its projected 21.82% net gain was 3% better than AbbVie's, and 29% more than Grifol's result, per analyst targets 9/10/18.WallStars
Sep 07, 2018 - Catalyst Biosciences is a clinical-stage biotech company focused on the treatment of hemophilia.After announcing preliminary results for a Phase 1/2 trial in June, Catalyst's market capitalization fel